United Therapeutics Corporation Capital Expenditures Incurred but Not yet Paid
United Therapeutics Corporation (UTHR) reported Capital Expenditures Incurred but Not yet Paid of $104.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-05
- United Therapeutics Corporation capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $4.50M, a 76.32% decline year-over-year.
- United Therapeutics Corporation capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $99.60M, a 111.02% increase year-over-year.
- United Therapeutics Corporation capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $24.10M.
- United Therapeutics Corporation capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $26.00M, a 356.14% increase year-over-year.
- United Therapeutics Corporation capital expenditures incurred but not yet paid for fiscal 2025 was $116.30M, a 423.87% increase from fiscal 2024.
- United Therapeutics Corporation capital expenditures incurred but not yet paid for fiscal 2024 was $22.20M, a 20.65% increase from fiscal 2023.
- United Therapeutics Corporation capital expenditures incurred but not yet paid for fiscal 2023 was $18.40M, a 26.90% increase from fiscal 2022.
- United Therapeutics Corporation capital expenditures incurred but not yet paid for fiscal 2022 was $14.50M, a 291.89% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 3 month as first filed | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 6 month as first filed | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 9 month as first filed | Capital Expenditures Incurred but Not yet Paid 12 month | Capital Expenditures Incurred but Not yet Paid 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $104.10M 10-Q · filed 2026-08-05 | $128.20M derived: sum of 3 quarters · filed 2026-08-05 | $154.20M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $99.60M 10-Q · filed 2026-05-06 | $123.70M derived: sum of 2 quarters · filed 2026-05-06 | $149.70M derived: sum of 3 quarters · filed 2026-05-06 | $168.70M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $24.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $50.10M derived: sum of 2 quarters · filed 2026-02-25 | $69.10M derived: sum of 3 quarters · filed 2026-08-05 | $116.30M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $26.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $45.00M derived: sum of 2 quarters · filed 2026-08-05 | $92.20M 10-Q · filed 2025-10-29 | $90.80M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $66.20M 10-Q · filed 2026-08-05 | $64.80M derived: sum of 3 quarters · filed 2026-08-05 | $70.50M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $47.20M 10-Q · filed 2026-05-06 | $45.80M derived: sum of 2 quarters · filed 2026-05-06 | $51.50M derived: sum of 3 quarters · filed 2026-05-06 | $45.80M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.30M derived: sum of 2 quarters · filed 2026-02-25 | -$1.40M derived: sum of 3 quarters · filed 2026-02-25 | $22.20M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $5.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2025-10-29 | $23.60M 10-Q · filed 2025-10-29 | $7.20M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | -$5.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $17.90M 10-Q · filed 2025-07-30 | $1.50M derived: sum of 3 quarters · filed 2026-02-25 | $3.60M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $23.60M 10-Q · filed 2025-04-30 | $7.20M derived: sum of 2 quarters · filed 2026-02-25 | $9.30M derived: sum of 3 quarters · filed 2026-02-25 | $23.60M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | -$16.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$14.30M derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $18.40M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $16.40M derived: sum of 2 quarters · filed 2024-10-30 | $34.80M 10-Q · filed 2024-10-30 | $35.50M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $14.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $32.70M 10-Q · filed 2024-07-31 | $33.40M derived: sum of 3 quarters · filed 2025-02-26 | $34.60M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $18.40M 10-Q · filed 2024-05-01 | $19.10M derived: sum of 2 quarters · filed 2025-02-26 | $20.30M derived: sum of 3 quarters · filed 2025-02-26 | $26.70M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.90M derived: sum of 2 quarters · filed 2025-02-26 | $8.30M derived: sum of 3 quarters · filed 2025-02-26 | $14.50M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $7.60M derived: sum of 2 quarters · filed 2023-11-01 | $13.80M 10-Q · filed 2023-11-01 | $13.50M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | $6.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $12.60M 10-Q · filed 2023-08-02 | $12.30M derived: sum of 3 quarters · filed 2024-02-21 | $13.00M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | $6.20M 10-Q · filed 2023-05-03 | $5.90M derived: sum of 2 quarters · filed 2024-02-21 | $6.60M derived: sum of 3 quarters · filed 2024-02-21 | $4.80M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $400.00K derived: sum of 2 quarters · filed 2024-02-21 | -$1.40M derived: sum of 3 quarters · filed 2024-02-21 | $3.70M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$1.10M derived: sum of 2 quarters · filed 2022-11-02 | $4.00M 10-Q · filed 2022-11-02 | $3.10M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | -$1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $3.30M 10-Q · filed 2022-08-03 | $2.40M derived: sum of 3 quarters · filed 2023-02-22 | -$100.00K derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $5.10M 10-Q · filed 2022-05-04 | $4.20M derived: sum of 2 quarters · filed 2023-02-22 | $1.70M derived: sum of 3 quarters · filed 2023-02-22 | $3.20M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | -$900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$3.40M derived: sum of 2 quarters · filed 2023-02-22 | -$1.90M derived: sum of 3 quarters · filed 2023-02-22 | $3.50M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | -$2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$1.00M derived: sum of 2 quarters · filed 2021-11-03 | $4.40M 10-Q · filed 2021-11-03 | $55.00M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $6.90M 10-Q · filed 2021-08-04 | $57.50M derived: sum of 3 quarters · filed 2022-02-24 | $57.40M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $5.40M 10-Q · filed 2021-05-05 | $56.00M derived: sum of 2 quarters · filed 2022-02-24 | $55.90M derived: sum of 3 quarters · filed 2022-02-24 | $54.10M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $50.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $50.50M derived: sum of 2 quarters · filed 2022-02-24 | $48.70M derived: sum of 3 quarters · filed 2022-02-24 | $54.50M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | -$1.90M derived: sum of 2 quarters · filed 2020-10-28 | $3.90M 10-Q · filed 2020-10-28 | -$2.80M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | -$1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $4.00M 10-Q · filed 2020-07-29 | -$2.70M derived: sum of 3 quarters · filed 2021-02-24 | -$1.90M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $5.80M 10-Q · filed 2020-04-29 | -$900.00K derived: sum of 2 quarters · filed 2021-02-24 | -$100.00K derived: sum of 3 quarters · filed 2021-02-24 | $3.40M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | -$6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$5.90M derived: sum of 2 quarters · filed 2021-02-24 | -$2.40M derived: sum of 3 quarters · filed 2021-02-24 | $11.50M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $4.30M derived: sum of 2 quarters · filed 2019-10-30 | $18.20M 10-Q · filed 2019-10-30 | $22.00M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | $3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $17.40M 10-Q · filed 2019-07-31 | $21.20M derived: sum of 3 quarters · filed 2020-02-26 | $21.90M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | $13.90M 10-Q · filed 2019-05-01 | $17.70M derived: sum of 2 quarters · filed 2020-02-26 | $18.40M derived: sum of 3 quarters · filed 2020-02-26 | $18.90M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $4.50M derived: sum of 2 quarters · filed 2020-02-26 | $5.00M derived: sum of 3 quarters · filed 2020-02-26 | $11.50M 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $1.20M derived: sum of 2 quarters · filed 2018-10-31 | $7.70M 10-Q · filed 2018-10-31 | $7.40M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $7.00M 10-Q · filed 2018-08-01 | $6.70M derived: sum of 3 quarters · filed 2019-02-27 | $6.50M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $6.50M 10-Q · filed 2018-05-02 | $6.20M derived: sum of 2 quarters · filed 2019-02-27 | $6.00M derived: sum of 3 quarters · filed 2019-02-27 | $6.10M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$500.00K derived: sum of 2 quarters · filed 2019-02-27 | -$400.00K derived: sum of 3 quarters · filed 2019-02-27 | $2.90M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | -$100.00K derived: sum of 2 quarters · filed 2017-10-25 | $3.20M 10-Q · filed 2017-10-25 | $1.90M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $3.40M 10-Q · filed 2017-07-27 | $2.10M derived: sum of 3 quarters · filed 2018-02-21 | $3.10M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-03-31 | $3.30M 10-Q · filed 2017-04-26 | $2.00M derived: sum of 2 quarters · filed 2018-02-21 | $3.00M derived: sum of 3 quarters · filed 2018-02-21 | $4.00M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2015-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$300.00K derived: sum of 2 quarters · filed 2018-02-21 | $700.00K derived: sum of 3 quarters · filed 2018-02-21 | $1.10M 10-K · filed 2018-02-21 | $1.08M 10-K · filed 2016-02-25 | |||
| 2015-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $2.00M derived: sum of 2 quarters · filed 2016-10-27 | $2.40M 10-Q · filed 2016-10-27 | $2.43M 10-Q · filed 2015-10-27 | $2.30M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $1.40M 10-Q · filed 2016-07-28 | $1.40M 10-Q · filed 2015-07-28 | $1.30M derived: sum of 3 quarters · filed 2017-02-22 | $171.00K derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2015-03-31 | $400.00K 10-Q · filed 2016-04-28 | $355.00K 10-Q · filed 2015-04-28 | $302.00K derived: sum of 2 quarters · filed 2017-02-22 | -$829.00K derived: sum of 3 quarters · filed 2017-02-22 | -$3.31M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2014-12-31 | -$98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | -$1.23M derived: sum of 2 quarters · filed 2017-02-22 | -$3.71M derived: sum of 3 quarters · filed 2017-02-22 | $3.20M 10-K · filed 2017-02-22 | $3.15M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | -$1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | -$3.61M derived: sum of 2 quarters · filed 2015-10-27 | $3.30M 10-Q · filed 2015-10-27 | $9.26M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | -$2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28 | $4.43M 10-Q · filed 2015-07-28 | $10.39M derived: sum of 3 quarters · filed 2016-02-25 | $10.76M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | $6.91M 10-Q · filed 2015-04-28 | $12.87M derived: sum of 2 quarters · filed 2016-02-25 | $13.24M derived: sum of 3 quarters · filed 2016-02-25 | $15.13M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $5.96M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $6.33M derived: sum of 2 quarters · filed 2016-02-25 | $8.22M derived: sum of 3 quarters · filed 2016-02-25 | $9.02M 10-K · filed 2016-02-25 | ||||
| 2013-09-30 | $369.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $2.25M derived: sum of 2 quarters · filed 2014-10-28 | $3.05M 10-Q · filed 2014-10-28 | $99.00K derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29 | $2.69M 10-Q · filed 2014-07-29 | -$270.00K derived: sum of 3 quarters · filed 2015-02-24 | -$1.40M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $799.00K 10-Q · filed 2014-04-29 | -$2.16M derived: sum of 2 quarters · filed 2015-02-24 | -$3.29M derived: sum of 3 quarters · filed 2015-02-24 | -$6.46M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | -$2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$4.08M derived: sum of 2 quarters · filed 2015-02-24 | -$7.26M derived: sum of 3 quarters · filed 2015-02-24 | $1.82M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | -$1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | -$4.31M derived: sum of 2 quarters · filed 2013-10-29 | $4.78M 10-Q · filed 2013-10-29 | $13.55M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | -$3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $5.90M 10-Q · filed 2013-07-25 | $14.68M derived: sum of 3 quarters · filed 2014-02-25 | $21.97M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $9.08M 10-Q · filed 2013-04-25 | $17.86M derived: sum of 2 quarters · filed 2014-02-25 | $25.15M derived: sum of 3 quarters · filed 2014-02-25 | $29.81M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $8.77M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $16.07M derived: sum of 2 quarters · filed 2014-02-25 | $20.73M derived: sum of 3 quarters · filed 2014-02-25 | $23.06M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $7.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $11.96M derived: sum of 2 quarters · filed 2012-11-01 | $14.29M 10-Q · filed 2012-11-01 | $15.37M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $4.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $7.00M 10-Q · filed 2012-07-26 | $8.08M derived: sum of 3 quarters · filed 2013-02-26 | |||||
| 2011-03-31 | $2.33M 10-Q · filed 2012-04-26 | $3.42M derived: sum of 2 quarters · filed 2013-02-26 | ||||||
| 2010-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $2.44M 10-K · filed 2013-02-26 | ||||||
| 2010-09-30 | $1.36M 10-Q · filed 2011-10-27 | |||||||
| 2009-12-31 | -$1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$6.87M derived: sum of 2 quarters · filed 2012-02-28 | $2.57M 10-K · filed 2012-02-28 | |||||
| 2009-09-30 | -$5.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $3.94M 10-Q · filed 2010-10-28 | ||||||
| 2009-06-30 | $9.44M 10-Q · filed 2010-07-28 | |||||||
| 2008-12-31 | $6.39M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |